SUN-322 Worsening of Carcinoid Syndrome during Lutetium Therapy in a Patient with Bronchial Carcinoid and Acromegaly

Introduction: Neuroendocrine tumors (NET) are uncommon, particularly when affecting the lungs having an incidence of 0.2 to 2 per 100,000. However, they represent 1-2% of all lung malignancies and up to 30% of all NET. In the context of Multiple Endocrine Neoplasia type 1 (MEN1), bronchial carcinoid...

Descripción completa

Detalles Bibliográficos
Autores principales: Baranski Lamback, Elisa, Gomes Henriques, Daniel, de Azeredo Lima, Carlos, Aparecida Silva, Debora, de Araujo Santos, Diego, Camacho, Aline, Chimelli, Leila, Gadelha, Monica
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Endocrine Society 2019
Materias:
Tumor Biology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552897/
http://dx.doi.org/10.1210/js.2019-SUN-322

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6552897/
http://dx.doi.org/10.1210/js.2019-SUN-322

Ejemplares similares